Ruschak, Amy M <br/><br/>
Novel proteasome inhibitors to overcome bortezomib resistance.  [electronic resource] 

 -  Journal of the National Cancer Institute  Jul 2011 
 - 1007-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djr160  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allosteric Site--drug effects<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Cell Line, Tumor<br/>Chloroquine--pharmacology<br/>Clioquinol--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>Humans<br/>Hydroxyquinolines--pharmacology<br/>Lactones--pharmacology<br/>Neoplasms--drug therapy<br/>Oligopeptides--pharmacology<br/>Protease Inhibitors--pharmacology<br/>Proteasome Endopeptidase Complex--chemistry<br/>Proteasome Inhibitors<br/>Pyrazines--pharmacology<br/>Pyrroles--pharmacology<br/>Threonine--analogs & derivatives<br/>Ubiquitinated Proteins--metabolism<br/>Ubiquitination--drug effects